MLB
Díaz's Scoreless Inning Doesn't Erase the Command Collapse—Dodgers Face a Postseason Bullpen Puzzle
Edwin Díaz threw a clean ninth in Triple-A on Wednesday, but seven walks in 4.1 rehab innings and an 11.85 ERA in the majors this season suggest the Dodgers can't rely on him for October leverage.

Edwin Díaz pitched a scoreless inning for Oklahoma City on Wednesday—his fifth Triple-A rehab appearance—working around a two-out double without inducing a whiff. The surface read: forward momentum. The underlying reality: a pitcher whose command has fractured so badly that even a quiet inning doesn't resolve the fundamental problem the Dodgers face heading into the final two weeks of the regular season.
The Dodgers signed Díaz to a three-year, $69 million deal expecting him to be a high-leverage weapon. Instead, his 2026 has been a catalog of setbacks: elbow surgery in April to remove loose bodies, then a five-month absence before August neck inflammation put him back on the IL. When healthy, he posted an 11.85 ERA with four blown saves in 11 opportunities before the latest injury ended his season. Through five rehab outings, he's allowed six runs in 4⅓ innings with seven walks and four strikeouts. That 12.46 ERA and walk-to-strikeout ratio isn't a small sample blip—it's a red flag about whether his arm mechanics have ever stabilized post-surgery. A single scoreless frame against Triple-A hitters doesn't change the data set. Manager Dave Roberts acknowledged this reality on Monday, telling reporters Díaz "could be left off the roster" entirely. "We have to go with our best pitchers, as far as performance, talent, all that stuff," Roberts said. The implicit message: Díaz has to earn his October slot.
The Dodgers' bullpen depth is enough to absorb his absence. They activated Kris Bubic from the 60-day IL on Wednesday after his May 14 injury with Kansas City, giving the left-hander a week and a half to prove he belongs in the postseason rotation. Roki Sasaki—last year's closer—is dealing with a right middle finger blister but could return to leverage duty once activated from his 15-day IL stint. Edgardo Henriquez's low-grade back strain showed no serious damage on imaging, meaning he's a realistic option to close postseason games if he's available. The organization has other arrows. Díaz's return-to-form becomes a bonus, not a necessity.
For bettors, this setup matters because Dodgers bullpen decisions directly affect leverage splits and game totals. If Díaz remains off the postseason roster—or if he's available but rarely used in high-pressure spots—the team's closer-usage and late-inning ERA profiles shift toward Sasaki and Henriquez. That's a tighter, more predictable bullpen from a prop perspective, because both have cleaner track records than Díaz's 2026 resume. Conversely, if the Dodgers gamble that one good rehab outing signals Díaz's readiness, they're introducing volatility into the late innings. A pitcher throwing seven walks in five rehab appearances will yield higher bullpen ERAs and more wildly swinging game scripts. The market hasn't yet priced how much roster uncertainty depresses Dodgers postseason moneylines and overs—teams with spottier bullpen health typically see their win probability decline 2-4% relative to preseason projections. That's baked into playoff-series pricing but may not be fully reflected in individual October game totals.